Sponsors

Mewburn Ellis is one of Europe's leading specialist intellectual property firms. We advise companies shaping the future of healthcare, helping them protect, commercialise and maximise the value of their innovative medicinal products and technologies to drive growth and deliver competitive advantage.

Combining legal excellence with deep scientific expertise, our IP attorneys, litigators and commercial lawyers deliver strategic advice across the full IP lifecycle in sectors where technical complexity and commercial stakes are high. Our expertise spans freedom to operate, regulatory protection, Supplementary Protection Certificates (SPCs), exclusivity optimisation and patent-regulatory listings, alongside licensing, partnering, transactions and due diligence. We also advise on complex cross-border disputes and contentious matters, enabling clients to navigate critical legal, regulatory and commercial challenges with confidence.

We are also at the forefront of UPC, acting for clients in many industries – including big pharma and biotech – before various local divisions. Our integrated team combines UPC litigation experience with market-leading patent prosecution, opposition and UK litigation capabilities, enabling us to develop and execute joined-up strategies across the patent lifecycle. This seamless collaboration helps clients strengthen and defend their patent portfolios, manage pan-European risk and opportunity, and maximise the value of their IP assets in an increasingly interconnected European landscape.